The Nasal Dendritic Cell-Targeting Flt3 Ligand as a Safe Adjuvant Elicits Effective Protection against Fatal Pneumococcal Pneumonia

We have previously shown that a pneumococcal surface protein A (PspA)-based vaccine containing DNA plasmid encoding the Flt3 ligand (FL) gene (pFL) as a nasal adjuvant prevented nasal carriage of Streptococcus pneumoniae. In this study, we further investigated the safety and efficacy of this nasal v...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kataoka, Kosuke, Fujihashi, Kohtaro, Oma, Keita, Fukuyama, Yoshiko, Hollingshead, Susan K., Sekine, Shinichi, Kawabata, Shigetada, Ito, Hiro-O, Briles, David E., Oishi, Kazunori
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2011
Témata:
Microbial Immunity and Vaccines
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191952/
https://ncbi.nlm.nih.gov/pubmed/21536790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.01360-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky